1. Home
  2. OGN vs BRZE Comparison

OGN vs BRZE Comparison

Compare OGN & BRZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.45

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Braze Inc.

BRZE

Braze Inc.

HOLD

Current Price

$20.23

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
BRZE
Founded
1923
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
2.1B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
OGN
BRZE
Price
$13.45
$20.23
Analyst Decision
Hold
Strong Buy
Analyst Count
5
26
Target Price
$11.40
$37.88
AVG Volume (30 Days)
2.4M
3.2M
Earning Date
05-07-2026
05-27-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$6,216,000,000.00
$738,182,000.00
Revenue This Year
$0.45
$22.69
Revenue Next Year
$1.67
$16.93
P/E Ratio
$24.40
N/A
Revenue Growth
N/A
24.40
52 Week Low
$5.69
$15.26
52 Week High
$13.49
$37.33

Technical Indicators

Market Signals
Indicator
OGN
BRZE
Relative Strength Index (RSI) 72.16 38.92
Support Level $10.05 $18.30
Resistance Level $13.46 $20.53
Average True Range (ATR) 0.05 1.39
MACD -0.12 -0.42
Stochastic Oscillator 60.71 1.05

Price Performance

Historical Comparison
OGN
BRZE

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.

Share on Social Networks: